Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Brain Behav Immun. 2013 Mar 16;32:9–18. doi: 10.1016/j.bbi.2013.03.003

Fig. 4.

Fig. 4

Alteration of cell fate by rAAV2-ssIL-1β induced inflammation. Experimental design showing tamoxifen (TAM) administration as well as intrahippocampal injections (A). MHC-II (red) staining demonstrating unilateral nature of inflammation in addition to YFP+ (green) cells in hippocampi that received ssIL-1β (B,C). Co-labeling of YFP+ cells with DCX to label neuroblasts (D), NeuN to label neurons (E), and GFAP to label reactive astrocytes (F). Arrowheads indicate double positive cells. Arrow indicates a NeuN−YFP+ cell. Scale bars = 10 μm.